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Abstract: Rhodothermus marinus is a halophilic extreme thermophile, with potential as a model
organism for studies of the structural basis of antibiotic resistance. In order to facilitate genetic studies
of this organism, we have surveyed the antibiotic sensitivity spectrum of R. marinus and identified
spontaneous antibiotic-resistant mutants. R. marinus is naturally insensitive to aminoglycosides,
aminocylitols and tuberactinomycins that target the 30S ribosomal subunit, but is sensitive to all 50S
ribosomal subunit-targeting antibiotics examined, including macrolides, lincosamides, streptogramin
B, chloramphenicol, and thiostrepton. It is also sensitive to kirromycin and fusidic acid, which
target protein synthesis factors. It is sensitive to rifampicin (RNA polymerase inhibitor) and to the
fluoroquinolones ofloxacin and ciprofloxacin (DNA gyrase inhibitors), but insensitive to nalidixic acid.
Drug-resistant mutants were identified using rifampicin, thiostrepton, erythromycin, spiramycin,
tylosin, lincomycin, and chloramphenicol. The majority of these were found to have mutations that
are similar or identical to those previously found in other species, while several novel mutations
were identified. This study provides potential selectable markers for genetic manipulations and
demonstrates the feasibility of using R. marinus as a model system for studies of ribosome and RNA
polymerase structure, function, and evolution.
Keywords: Rhodothermus marinus; antibiotic-resistance mutation; ribosome; RNA polymerase;
halophile; thermophile
1. Introduction
Extremophilic organisms are important model systems for investigating macromolec-
ular structure, function and evolution. Macromolecular complexes such as the ribosome
are important antibiotic targets and their structural studies have significantly advanced our
understanding of antibiotic modes of action and mechanisms of antibiotic resistance [1–3].
Ribosomes from thermophiles have historically been attractive targets for structural stud-
ies due to their greater conformational homogeneity. Such investigations can potentially
reveal the basis for adaptation to extreme environments, especially when coupled to ge-
netic approaches. While the most thoroughly examined thermophilic organism is the
bacterium Thermus thermophilus, studies of other, phylogenetically distant thermophiles
could potentially facilitate a comparative approach. This is especially relevant to the extent
that species-specific idiosyncrasies, such as differences in DNA repair patterns or codon
usage bias, can influence the spectrum of mutants arising. Such idiosyncrasies provide a
compelling motivation to explore novel model systems.
Rhodothermus marinus R-10T is a Gram-negative, non-motile, non-spore-forming, ther-
mophilic and halophilic bacterium isolated from a submarine hot spring off the coast of
Iceland [4]. It grows optimally at a temperature of 65 ◦C and a salinity of approximately
2%, making it both a model thermophile and a model halophile [5]. Based on 16S rRNA
sequence comparisons, the genus Rhodothermus has been classified as a member of the
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Rhodothermaceae, branching deeply within the phylum Bacteroidetes, with its closest relative
being the mesophilic, extremely halophilic genus Salinibacter [6,7]. Other genera of the
Rhodothermaceae include Salisaeta [8], Rubricoccus [9], Rubrivirga [10], Longimonas [11], and
Longibacter [12]. All members are halophilic and either aerobic or facultatively anaero-
bic; all but Rhodothermus are mesophilic, suggesting that adaptation of Rhodothermus to
growth at high temperature is a derived rather than a primitive character. Its affinity with
Salinibacter suggests that adaptation to hypersaline environments predates development of
thermostability. This stands in contrast to members of the genus Thermus, which form part
of a phylum that branches deeply in the universal phylogenetic tree, and for whom thermal
adaptation is likely a primitive character. Interestingly, R. marinus was isolated from the
same environmental sample as the halotolerant IB-21 strain of Thermus thermophilus [13],
providing an opportunity to compare independently arising adaptations to the same ther-
mal environment. This species is thus of great intrinsic interest from the standpoint of
microbial evolution.
We have begun to develop R. marinus as a model system for genetic and structural
studies of the ribosome and potentially other macromolecular complexes. Like other
extremophiles, R. marinus has become an important subject of protein structural studies.
Notable examples include a novel respiratory complex III [14] and the ribosomal protein
uL16 arginyl hydroxylase [15]. Although structures of DNA gyrase, RNA polymerase, and
the ribosome from R. marinus have yet to be solved, these would seem promising subjects
for structural studies given their important roles as targets for major antibiotic classes.
Here, we describe antibiotic-resistant mutants of R. marinus with alterations in cellular
components responsible for gene expression.
R. marinus has a number of advantages as a potential model organism for the study
of the protein synthesis. In contrast to most other bacteria, the R. marinus genome has a
single rrn operon [16,17], facilitating the isolation of rRNA mutants with pure populations
of mutant ribosomes. Early attempts to isolate E. coli rRNA mutants were hampered by the
presence of seven rrn operons such that even dominant mutations arising in a single operon
fail to express a selectable phenotype; isolation of such mutants required either expression
of rRNA from multi-copy plasmids [18] or deletion of multiple rrn operons [19]. In general,
ribosome structural studies can be impaired by the complication of mixed populations of
mutant and wild-type ribosomes from species with multiple rrn operons. More recently,
isolation of pure rRNA mutants of Mycobacterium spp. [20] or T. thermophilus [21] has been
facilitated by deletion of one of only two rRNA operons. In the latter organism, isolation
of antibiotic-resistant mutants could also arise by efficient homologous recombination
between rRNA gene copies during antibiotic selection [22]. While R. marinus is not naturally
competent for transformation, a method of DNA transfer by electroporation has been
described [23] and targeted gene disruptions have been constructed [24]. There is thus
significant potential for developing this species as a genetic system [25].
Here, we describe a collection of R. marinus mutants having base substitutions in
rRNA, or amino acid substitutions or deletions in ribosomal proteins or RNA polymerase.
In most instances, these mutations are similar or identical to those found in T. thermophilus
or mesophilic bacteria. Some mutations, specifically those affecting ribosomal protein uL4,
have not been previously observed.
2. Results
2.1. Spectrum of Antibiotic Sensitivity
Before selecting resistant mutants, we established the range of antibiotics inhibitory to
R. marinus. Although the sensitivity of R. marinus to several antibiotic classes was reported
in the initial description of the genus [4], we undertook a more expansive survey. This was
done using a simple zone of inhibition disc assay (see Materials and Methods). Results
from these assays are indicated in Tables 1 and S2. We examined antibiotics targeting
the ribosome and associated factors, as well as drugs targeting RNA polymerase or DNA
gyrase. Assays showing no zone of inhibition were interpreted as indicating resistance.
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Table 1. Antibiotic sensitivity spectrum of R. marinus R-10T. Sensitivity was assessed using a disc assay to measure zones
of inhibition.
Antibiotic Class, (Target) Antibiotic Response
aminoglycoside (ribosome, 30S) streptomycin, apramycin, hygromycin B, gentamicin, neomycin,neamine, ribostamycin, kanamycin, tobramycin, paromomycin resistant
aminocyclitols (ribosome, 30S) kasugamycin, spectinomycin resistant
tuberactinomycin (ribosome, 70S) capreomycin resistant
14-atom macrolides (ribosome, 50S) erythromycin, oleandomycin, roxithromycin, clarithromycin sensitive
15-atom macrolide (ribosome, 50S) azithromycin sensitive
16-atom macrolides (ribosome, 50S) spiramycin, chalcomycin, tylosin, carbomycin sensitive
lincosamides (ribosome, 50S) lincomycin, clindamycin sensitive
streptogramin B (ribosome, 50S) pristinamycin sensitive
pleuromutilin (ribosome, 50S) tiamulin sensitive
amphenicol (ribosome, 50S) chloramphenicol sensitive
thiopeptide, (ribosome, 50S) thiostrepton sensitive
elfamycin (EF-Tu) 1 kirromycin sensitive
fusidane (EF-G) 2 fusidic acid sensitive
rifamycin (RNA polymerase) rifampicin sensitive
quinolone (DNA gyrase) nalidixic acid resistant
fluoroquinolones (DNA gyrase) ofloxacin, ciprofloxacin sensitive
1 EF-Tu, protein synthesis elongation factor Tu. 2 EF-G, protein synthesis elongation factor G.
We found R. marinus to be insensitive to all 30S ribosomal subunit antibiotics we
tested. We confirmed the previous report of intrinsic resistance of R. marinus to the amino-
glycosides streptomycin, kanamycin and gentamicin [4] and also found resistance to
a number of other aminoglycosides (apramycin, tobramycin, neomycin, paromomycin,
neamine, ribostamycin, and hygromycin B). R. marinus is also insensitive to the aminocyli-
tols spectinomycin and kasugamycin. We observed resistance to capreomycin, a member
of the tuberactinomycins, which binds at the 30S–50S subunit interface, consistent with
the previously observed cross-resistance of aminoglycoside-resistant mutants to capre-
omycin [22,26], suggesting a common basis for insensitivity to both classes of drugs. All
other antibiotics showed significant zones of inhibition. We confirmed sensitivity to lin-
comycin, erythromycin, chloramphenicol, and pristinamycin, all of which bind in or near
the peptidyltransferase active site of the 50S subunit. Additional macrolides producing inhi-
bition included the 14-atom macrolides oleandomycin, roxithromycin, and clarithromycin,
the 15-atom macrolide azithromycin, and the 16-atom macrolides spiramycin, chalcomycin,
tylosin, and carbomycin. The pleuromutilin tiamulin, another inhibitor of peptide bond
formation, also inhibits growth of R. marinus. In summary, R. marinus is resistant to all
30S inhibitors tested and sensitive to all 50S subunit inhibitors tested. Sensitivity was also
found to kirromycin and fusidic acid, which target protein synthesis factors EF-Tu and
EF-G, respectively. Among non-ribosomal drugs, we found R. marinus to be sensitive to
the RNA polymerase inhibitor rifampicin and to the DNA gyrase inhibitors ofloxacin and
ciprofloxacin, but, as previously reported [4], insensitive to nalidixic acid.
2.2. Selection of Spontaneous Mutants
Selection of resistant mutants was attempted with a number of drugs, including the
RNA polymerase inhibitor rifampicin, the protein synthesis inhibitors chloramphenicol,
lincomycin, erythromycin, spiramycin, tylosin, oleandomycin, thiostrepton, and fusidic
acid, and the gyrase inhibitors ofloxacin and ciprofloxacin. Resistant mutants arose on ri-
fampicin, chloramphenicol, lincomyin, erythromycin, spiramycin, tylosin and thiostrepton.
No mutants appeared on oleandomycin, fusidic acid, ofloxacin or ciprofloxacin, although a
more exhaustive search on a wider range of drug concentrations could potentially reveal
mutants resistant to these drugs. Individual isolates were purified and analyzed by se-
quencing the genes known from previous studies to be the likely sites of mutations. Based
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on our own studies with T. thermophilus [22], we had no reason to expect major differences
in the general location of these mutations compared with mesophilic species.
2.3. Rifampicin-Resistance (RifR) Mutations in the RNA Polymerase β Subunit
Rifampicin inhibits bacterial transcription by binding to the β subunit of RNA poly-
merase, and mutations conferring resistance are generally found in rpoB, the gene encoding
the β subunit. We identified three independent R. marinus RifR alleles of rpoB (locus tag
RMAR_RS05525). These included rpoB1 (GTC to TTC) producing the amino acid substitu-
tion V146F; rpoB2 (GCC to GTC) producing A522V; and rpoB3 (GCA to TCA) producing
H526Y (Figure 1A; E. coli amino acid residue numbering). Mutations at these positions have
been found in other species (reviewed by [27]) and are located in or near the rifampicin
binding site (Figure 1B; pdb entry 6ccv [28]).
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compassing sites of RifR mutations. (B) Structu e of the rifampic binding site within Mycobacterium s egmatis RNA
polymerase [28], showing positions corresponding to sites of RifR mutations in the R. marinus RNA polymerase β subunit.
2.4. Thiostrepton-Resistance Mutations in the 50S Ribosomal Subunit
Thiostrepton is a peptide antibiotic that acts as an inhibitor of EF-G-dependent translo-
cation and binds to the 50S ribosomal subunit in a cleft formed by ribosomal protein
uL11 and its binding site on 23S rRNA. The uL11 binding site itself is formed by two 23S
rRNA loops (residues 1065–1073 and 1093–1098) brought to eth r by a series of tertiary
interactions (Figure 2A). Thiostrepton makes direct contact with A1067 and A1095 in these
two loops and resistance can occur by base substitutions at either position, by enzymatic
2′-O-methylation of A1067, or by amino acid substitutions, deletions or insertions in uL11
(reviewed by [29]). We sequenced rrlA encoding 23S rRNA (locus tag RMAR_RS000900)
and rplK encoding uL11 (locus tag RMAR05505) of the ThiR mutants. While we did not
identify any changes in uL11, all mutants were found to have alterations at or near A1067
of 23S rRNA (Fig re 2). The e included an A1067C transversion, a deletion of A1069
(∆A1069), a duplication of A1069 (A1069AA), or a duplication of G1071 (G1071GG). As
seen in the Deinococcus radiodurans 50S ribosomal subunit-thiostrepton complex [29], A1067
is within a few Ångstroms of thiostrepton (Figure 2B), such that 2′-O-methylation could
sterically block drug binding. The mechanism of resistance conferred by a base substitution
at this position is not clear, but it presumably creates sufficient local distortion to decrease
binding affi ity. In co trast, changes at A1069 a d G1071 are further away and ust
act more indirectly; residues 1067, 1068 and 1069 form a continuous base stack such that
duplications or deletions of any of these residues could lead to repositioning of A1067.
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G1071 participates in a base triple with the G1091-C1100 base pair, which in turn is stacked
on a base triple involving C1072, C1092 and G1099. Duplication of G1071 could destabilize
the tertiary interaction between the two loops, thereby repositioning either A1067 or A1095,
or both. This tertiary interaction is more directly stabilized by single hydrogen bonds
between the N2 of G1068 and the O3′ of A1095, and between the O4′ of A1069 and the
O2′ of A1096. Duplication or deletion of A1069 could easily disrupt these interactions and
influence the positioning of A1067 and A1095.
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of methylation by resistance methyltransferases, is shown as a pink sphere.
2.5. Base Substitutions of 23S rRNA Residues in and around the Ribosomal Peptidyltransferase
Active Site
The peptidyltransferase active site is situated deep within the 50S ribosomal subunit,
and X-ray cr stal structur s of th bacterial ribosome in complex with transition st te
analogs indicate that all direct contacts with substrates in the active site involve residues of
23S rRNA [30]. Chloramphenicol, macrolides, lincosamides, streptogramin B, and various
other antibiotics bind at or near this site, and in many cases mutually compete for binding
(for an extensive review of antibiotic action, see [31]). While chloramphenicol, lincosamides,
streptogramin B and some macrolides are bona fide peptidyltransferase inhibitors, other
macrolides impair elongation of the nascent peptide by occluding the peptide exit channel;
more cent studies have shown that macrolid inhi it the synthesis of a subset of protei s
rather than inhibiting global translation (reviewed by [32]).
Chloramphenicol-resistant (ChlR) mutants of R. marinus were readily identified (Table 2)
and occur at multiple sites within the central loop of 23S rRNA domain V, corresponding
to the peptidyltransferase active site. These included A2059G, G2061C, A2062C, A2453C,
U2500A, A2503C, A2503G, and U2504G. Each of these utations is consistent with our
previous studies with T. thermophilus. The most abundant mutation was A2058G, perhaps
one of the most frequently described antibiotic-resistance mutation in the ribosome and was
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found independently in selections for erythromycin- (EryR), spiramycin- (SpiR), tylosin-
(TylR), and lincomycin-resistant (LinR) mutants.
Table 2. Mutations identified in this study. Abbreviations: Rep Strain, representative strain; Chl,
chloramphenicol; Ery, erythromycin; Spi, spiramycin; Tyl, tylosin; Lnc, lincomycin; Thi, thiostrepton;
Rif, rifampicin.
Allele Rep Strain Mutation Selection
rpoB1 SOP89 RNA pol β subunit-V146F Rif50, 100
rpoB2 SOP90 RNA pol β subunit-A522V Rif50, 100
rpoB3 SOP91 RNA pol β subunit-H526Y Rif50
rrlA1 SOP9 23S rRNA-G2057A Ery50, 100, 200
rrlA2 SOP23 23S rRNA-A2058C Ery200
rrlA3 SOP11 23S rRNA-A2058G Ery50, 100, 200/Spi100/Tyl100/Lnc100
rrlA4 SOP26 23S rRNA-A2059G Ery200/Chl100
rrlA5 SOP56 23S rRNA-G2061C Chl100/Lnc100
rrlA6 SOP29 23S rRNA-A2062C Chl25/Ery50/Spi100
rrlA7 SOP38 23S rRNA-A2062G Chl25/Ery50
rrlA8 SOP74 23S rRNA-A2453C Chl25
rrlA9 SOP5 23S rRNA-U2500A Chl50
rrlA10 SOP4 23S rRNA-A2503C Chl50
rrlA11 SOP1 23S rRNA-A2503G Chl25, 50
rrlA12 SOP3 23S rRNA-U2504G Chl25, 50
rrlA13 SOP14 23S rRNA-U2611G Ery50
rrlA14 SOP7 23S rRNA-A2453C/U2500A Chl50
rrlA15 SOP24 23S rRNA-G2057A/A2062G Ery200
rrlA16 SOP60 23S rRNA-A2062G/A2503G Spi100
rrlA17 SOP72 23S rRNA-A1067C Thi200
rrlA18 SOP79 23S rRNA-∆A1069 Thi100
rrlA19 SOP73 23S rRNA-A1069AA Thi200
rrlA20 SOP77 23S rRNA-G1071GG Thi100
rplD1 SOP57 uL4-K58N, ∆L59-Y60 Ery100, 200
rplD2 SOP25 uL4-∆A50-R69 Ery200
rplD3 SOP16 uL4-∆T65-G82 Ery100
In addition, several double mutants were identified. These include A2453C/U2500A,
selected on chloramphenicol; G2057A/A2062G, selected on erythromycin; and A2062G/
A2503G, selected on spiramycin. The A2062G/A2503G double substitution is especially
interesting in that A2062 and A2503 form a symmetrical base pair with one another via
their Hoogsteen faces with two N6-N7 hydrogen bonds; either mutation alone could be
isolated on chloramphenicol, while A2062G was isolated on either chloramphenicol or
erythromycin (Figure 3). The appearance of multiple base substitutions is unusual and
not easily explained but could be indicative of a high natural mutation frequency or stress-
induced mutagenesis. Our protocols for selection of mutants are designed to minimize
exposure to drug. Further studies will be needed to address this question. All of these
residues are within close proximity to the corresponding drug binding sites as observed in
T. thermophilus ribosome crystal structures (Figure 3B,C) [33].
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Figure 3. Sites of mutations in or near the peptidyltransferase active site of 23S rRNA. (A) Secondary structure of Rhodother-
mus marinus central loop of domain V of 23S rRNA, with sites of mutations indicated, along with resistance phenotypes
conferred. Three-dimensional structure of the peptidyltransf rase center of Thermus thermophil 70S ribosome in complex
with (B) erythromycin (pdb entry 6n 6) and (C) chloramphenicol (pdb entry 6nd5). For panels (B,C), rythromycin or
chloramphenicol are shown as green sticks; sites of mutations conferring resistance are colored blue.
2.6. Deletions in a Conserved Loop of Ribosomal Protein uL4 Conferring Erythromycin Resistance
While the peptidyltransferase active site is composed of rRNA, several proteins have
globular domains situated on the subunit surface and extended structures that approach
the active site, including uL2, uL3, uL4, and bL27 [30]. Proteins uL4 and uL22 form part
of the polypeptide exit channel, near the binding site for macrolides. In a number of
pathogenic organisms, resistance to erythromycin or other macrolides has been found to
result from mutations in rplD or rplV, encoding 50S ribosomal proteins uL4 and uL22,
respectively (reviewed by [34]). A large collection of mutations in both these proteins in
E. coli reveal a wide range of mutations conferring macrolide resistance [35].
We identified a number of R. marinus mutants selected for resistance to several
macrolides, including erythromycin, spiramycin, and tylosin, and sequenced both rplD
and rplV of each of these. No mutations in rplV were found in any mutant. Several EryR
mutants were found to have deletions within rplD (locus tag RMAR_RS04205), initially
noted by the diminished size of PCR products as viewed by agarose gel electrophoresis.
Sequencing confirmed that the rplD genes of these mutants had deletions in the region
corresponding to the loop of uL4 that extends toward the peptidyltransferase center and
polypeptide exit channel where erythromycin binds.
Three distinct deletion mutations were identified in rplD (Figure 4). One of these, an
out-of-frame deletion of the sequence 5′-GCTGTA-3′, results in both a K58N substitution
and the deletion of L59 and Y60. A second allele, consisting of a 60-base pair, 20-amino acid
deletion extending from A50 to R69, appears to be the result of homologous recombination
between two short, direct repeats of the sequence 5′-CGGGCCG-3′. The third allele, a
54-bp, 18-amino acid deletion removing T65 to G82, appears to be the result of homologous
recombination between direct repeats of the sequence 5′-GGTACGG-3′ (Figure S1). The
Antibiotics 2021, 10, 1384 8 of 14
original E. coli erythromycin-resistance mutation, eryA [36], resulted in a K63E substitution
in the same region of uL4 [37]. Several site-directed mutagenesis studies of E. coli uL4 have
demonstrated the malleability of this extended loop and its role in macrolide-ribosome
interactions [38–40]. However, we are not aware of spontaneous deletions of uL4 of this
magnitude having been previously reported.
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Figure 4. Erythromycin-resistance mutations affecting ribosomal protein uL4. (A) Partial sequence alignment of ribosomal
proteins uL4 from Escherichia coli (Eco), Thermus thermophilus (Tth), and Rhodothermus marinus (Rma) highlighting sights of
erythromycin-resistance mutations. (B–E) Three-dimensional structure showing the interaction with the extended loop
f ribosomal prot in uL4 and the erythromycin binding site of 23S rRNA, illustrated using the Thermus thermophilus 70S
ribos me-erythromycin complex (pdb entry 6nd6). For clarity, only several 23S rRNA nucleotides and the extended loops
of uL4 are shown. Residues mutate are colored blue. (B) The eryA K63E mutation from E. coli. (C) The R. marinus rplD1
(K58N, ∆L59-Y60) mutation. (D) The R. marinus rplD2 (∆A50-R69) mutation. (E) The R. marinus rplD3 (∆T65-G82) mutation.
Each of these mutations is expected to perturb RNA conformation in the macrolide binding site.
3. Discussion
R. marinus is both extremely thermophilic and halophilic, making it quite distinct
physiologically from other organism that have been the subject of study of antibiotic
action and mechanisms of resistance. Nevertheless, it is remarkable that many of the
same mutations that confer antibiotic resistance in mesophiles also confer resistance in
extremophiles such as T. thermophilus and R. arinus. Thus, the majority of the mutations
we identified in this study are identical to those observed in a wide range of organisms,
though our collection of R. marinus mutants is larger than most reported in individual
species in a single study. Most of the base substitutions in the peptidyltransferase active site
re at positions in close cont ct with various a tibiotics, as observed in crystal tructures
of rib some-antibi tic omplexes (reviewed by [3]). Th same can be said of the RNA
polymerase mutants we found. This similarity is no doubt the result of the extreme
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conservation of rRNA sequence and structure in ribosome functional centers, and the
catalytic center of RNA polymerase.
A number of high-resolution structures of the T. thermophilus RNA polymerase have
been determined in various complexes [41–43], including with rifampicin [44]. More
recently, the structure of the M. smegmatis RNA polymerase-rifampicin complex has been
solved [28]. Of the R. marinus RNA polymerase residues mutated in RifR mutants, V146
and H526 are both quite conserved, whereas A522 is less so. Substitutions at H526 are
among the more frequently observed RifR mutations in Mycobacterium tuberculosis [27]. As
seen in the M. smegmatis RNA polymerase-rifampicin complex [28], all three residues are
within the rifampicin binding site, although A522 is somewhat removed from rifampicin
such that the mechanism of resistance caused by substitutions at this position is unclear
(Figure 1B). It is perhaps worth noting that this position is a Ser in E. coli, M. tuberculosis,
and T. aquaticus. While none of these residues make direct contact with the drug, their
exchange with bulkier residues is likely to have a strong steric effect on drug binding.
Crystal structures of antibiotics bound to the peptidyltransferase center help to explain
their mechanism of action [3]. As illustrated in Figure 3, base substitutions conferring drug
resistance are components of the drug binding site. In the case of erythromycin-resistance,
sites of mutations are located in close proximity to the drug, and the same is true for
chloramphenicol-resistance. Consistent with this observation, mutations simultaneously
conferring resistance to both drugs are located between the two drug binding sites. Further,
crystal structures of ribosomes containing antibiotic-resistance mutations show small
perturbations in local structure or indicate a loss of ribosome-drug contact [45]. In contrast
to sites of rRNA mutations, ribosomal protein mutations are less similar across species. This
is probably in part due to the lower conservation of ribosomal protein sequences, but more
likely the lack of conservation at the DNA sequence level, which constrains the specific
mutations that can occur. The deletion mutations in rplD observed in R. marinus are the
result of recombination between short, fortuitously repeated DNA sequences. Synonymous
codons at either of these repeats would presumably prevent these particular deletions
from arising.
The finding of deletion mutations in uL4 is consistent with previously identified
mutations in this protein. The original E. coli eryA allele of rplD was found to result in
a single amino acid substitution, K63E [37] (Figure 4B). This mutation was subsequently
found to cause an increase in the frequency of translational errors, including misreading
errors and frameshifting [46]. While an assay for measuring translational accuracy does
not yet exist for R. marinus, it should be possible to assess their effects by reconstructing
the analogous deletions in E. coli rplD. While there is as yet no high-resolution structure
of the R. marinus ribosome, structures of ribosomes from a variety of organisms indicate
that the loop subjected to these deletion mutations is located in close proximity to 23S
rRNA residues involved in erythromycin binding. A wide variety of amino acid substi-
tutions as well as small deletions (1 to several residues) in this loop have been found in
multiple species.
The lack of direct contact between uL4 and erythromycin demands consideration of
an indirect mechanism of resistance, such as a local destabilization of rRNA conformation.
The deletions could be mapped onto the T. thermophilus ribosome crystal structure and
it is clear that they must abolish any direct contact with 23S rRNA in the erythromycin
binding site (Figure 4C–E). This notion is consistent with a previous chemical probing
study [47] and subsequent cryo-electron microscopic reconstruction [48] of the E. coli
uL4 mutant, both of which showed significant structural distortion from a single amino
acid substitution. We would expect the R. marinus deletions to make substantially greater
distortions. A crystal structure of an archaeal 50S subunit bearing a 3 amino acid deletion in
ribosomal protein uL22 shows the repositioning of several bases in the peptidyltransferase
center [45]. Remarkably, the extended loops of both uL4 and uL22 of E. coli are dispensable
for protein synthesis and growth but make important contributions to the kinetics and
fidelity of 50S subunit assembly [40]. We expect that the deletions within uL4 will show
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extensive distortions, and future cryo-EM reconstructions of the R. marinus ribosome could
be effective in testing this hypothesis.
The finding that R. marinus is resistant to aminoglycosides, capreomycin, kasugamycin,
and spectinomycin, was unexpected. One possible explanation is an inability to import
these drugs into the cell, and given the close structural relationship of the aminoglycosides,
a common uptake mechanism seems plausible. Members of the Bacteroides genus are inher-
ently resistant to aminoglycosides due to lack of an oxygen- or nitrate-dependent electron
transport system [49]. This explanation is insufficient to explain resistance of R. marinus,
which is obligately aerobic. Another possibility is natural variation in ribosome structure.
Inspection of the 16S rRNA sequence revealed variation in the aminoglycoside binding
site, a A1409-U1491 base pair, as opposed to the C1409-G1491 more frequently found in
bacterial 16S rRNAs. Data retrieved from the Comparative RNA Web Site and Project
database (http://www.rna.ccbb.utexas.edu; accessed on 9 August 2020) [50] indicate that
among bacterial sequences, a C-G pair is found in 84.5% of bacterial 16S rRNA sequences,
while an A-U base pair is found in 12.6% of sequences. These data also indicate that
the adjacent base pair, 1410–1490, is C-G in R. marinus, a sequence found in only 0.1% of
bacterial 16S rRNA sequences. The mesophilic extreme halophile Salinibacter ruber, whose
closest relative is R. marinus, is also resistant to kanamycin and its 16S rRNA also has
the A1409-U1491 base pair [6,7]. Based on secondary structure models retrieved from the
RNAcentral database (http://rnacentral.org/; accessed on 9 August 2020) [51], this same
A-U base pair is present in all members of the Rhodothermaceae. Whether or how either of
these base pair identities might influence the aminoglycoside binding site is not obvious.
Previous studies have found the aminoglycoside-resistance mutations C1409G of yeast
mitochondrial 17S rRNA [52], or a G1491A of Tetrahymena thermophila 18S rRNA [53]. This
would also explain the resistance to capreomycin, as these mutations confer cross-resistance
to tuberactinomycins. In the absence of an in vitro protein synthesis system for R. marinus,
it is not yet possible to distinguish between these two possible explanations for resistance
to aminoglycosides and capreomycin.
4. Materials and Methods
4.1. Strains and Growth Conditions, Assessment of Antibiotic Sensitivity, and Isolation
of Mutants
All mutants were derived from R. marinus R-10T ATCC 43812/DSM 4252 [4], which
was a kind gift of JHD Cate, University of California, Berkeley. R. marinus was cultivated
in liquid TEM medium (ATCC Medium 1598) containing 2% NaCl (referred to hereafter
as TEMS medium) or on TMG medium containing 2% NaCl (referred to hereafter as
TMGS medium). TMG medium consists of TEM lacking phosphate buffer and solidified
with gelrite at a concentration of 1.1%. All cultures were grown at 65 ◦C under aerobic
conditions with vigorous aeration at 200 rpm in a New Brunswick Innova 42 Shaker
Incubator. Overnight cultures were typically cultivated in 20 mL of medium in 125 mL
baffled culture flasks (Corning).
To assay antibiotic sensitivity, 100 µL of a saturated overnight culture grown in TMGS
broth was spread-plated onto TMGS plates. A disc infused with 100 µg of antibiotic was
placed onto the surface of the plate, which was then incubated at 65 ◦C overnight; zones of
inhibition were subsequently measured. Spontaneous mutants were selected by spreading
approximately 109 cells from a saturated overnight culture onto TMGS plates containing
various antibiotic concentrations; chloramphenicol, 25, 50, or 100 µg/mL; erythromycin, 50,
100, or 200 µg/mL; tylosin, 100 µg/mL; spiramycin, 100 µg/mL; lincomycin, 100 µg/mL;
thiostrepton, 25, 50, 100, or 200 µg/mL; rifampicin, 50, 100, or 200 µg/mL. Mutants were
purified by restreaking onto TMGS medium containing antibiotic at the same concentration
used in selection, then a second time on antibiotic-free TMGS. Mutants were never exposed
to antibiotic after the initial single colony isolation. Single colonies were used to inoculate
TEMS medium and shaken at 65 ◦C to saturation. Mutants were archived as 25% glycerol
stocks at −80 ◦C.
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4.2. Identification of Mutations
Chromosomal DNA (gDNA) was prepared using Wizard Genomic DNA Kit (Promega,
Madison, WI, USA). Oligonucleotide primers were synthesized by IDT and are described
in Supplementary Table S1. All PCR reactions were performed using OneTaq DNA poly-
merase (New England Biolabs, Ipswich, MA, USA). Sanger sequencing of PCR products
was performed by the Genomics and Sequencing Center at The University of Rhode
Island. The rrnA operon encoding 16S rRNA (locus tag RMAR_RS00885), tRNAIle (lo-
cus tag RMAR_RS00890), tRNAAla (locus tag RMAR_RS00895), 23S rRNA (locus tag
RMAR_RS00900), and 5S rRNA (locus tag RMAR_ RS00905), was amplified using primers
Rma_rrnA_f3 and Rma_rrnA_r3, with a 58 ◦C annealing temperature and a 6 min extension
time. The rplD gene encoding ribosomal protein uL4 (locus tag RMAR_RS04205) was ampli-
fied using primers Rma_rplD_f1 and Rma_rplD_r1, with a 52.5 ◦C annealing temperature
and a 1 min extension time. The rplV gene encoding ribosomal protein uL22 (locus tag
RMAR_RS04225) was amplified using primers Rma_rplV_f1 and Rma_rplV_r1, with a
49 ◦C annealing temperature and a 1 min extension time. The rplK gene encoding riboso-
mal protein uL11 (locus tag RMAR_RS05505) was amplified using primers Rma_rplK_f1
and Rma_rplK_r1, with a 60 ◦C annealing temperature and a 1 min extension time. The
rpoB gene encoding the β-subunit of RNA polymerase (locus tag RMAR_RS05525) was
amplified using primers Rma_rpoB_f1 and Rma_rpoB_r1, with a 49 ◦C annealing tem-
perature and a 4 min extension time. Sequencing of the rrlA gene encoding 23S rRNA
was performed using primers Rma_rrnA_f4, Rma_rrnA_f7, Rma_rrnA_f8, Rma_rrnA_r5,
Rma_rrnA_r6, Rma_rrnA_r7.
5. Conclusions
Antibiotic sensitivity spectra and patterns of cross resistance can potentially be infor-
mative from both phylogenetic and ribosome structure-function perspectives. Extensive
surveys of antibiotic-resistance mutations have been conducted for only a handful of
species, making broad generalizations difficult. In this study, we have isolated and charac-
terized a number of antibiotic-resistant mutants of a single species, potentially allowing
direct comparisons of mutant phenotypes. Importantly, we find that mutations arising
in a thermophilic-halophilic species closely resemble those found in mesophilic species,
consistent with the extreme sequence conservation (and by implication, structural con-
servation) of antibiotic-binding sites in RNA polymerase and the ribosome. Surprising
was the inherent resistance of this species to a range of structurally-unrelated 30S subunit
inhibitors. The basis for this resistance remains to be determined. The ability to readily
isolate rRNA mutations in this species makes it a candidate for future structural studies to
address this question.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/antibiotics10111384/s1, Figure S1: Generation of rplD erythromycin-resistance mutations [54];
Table S1: Oligonucleotides used in this study [17]; Table S2: Antibiotic zones of inhibition.
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